Article
An effect of the PAI-1 4G/5G polymorphism on cholesterol levels may explain conflicting associations with myocardial infarction and stroke.
Cerebrovascular diseases (Basel, Switzerland) - 1 Jan 2006
Boncoraglio Giorgio B, Bodini Antonella, Brambilla Carla, Carriero Maria Rita, Ciusani Emilio, Parati Eugenio A
Abstract excerpt
BACKGROUND AND PURPOSE: The gene-encoding plasminogen activator inhibitor type 1 (PAI-1) has a common 4G/5G 'functional' polymorphism, and people homozygous for the 4G allele have higher PAI-1 plasma concentrations. The 4G/4G genotype is associated with increased risk of myocardial infarction but paradoxically protects against stroke. We hypothesized that this paradox may be explained via an effect of the PAI-1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
